Richard A Miller, Corvus Pharmaceuticals, Inc.'s President and CEO and a director of the company, recently acquired 12,000 shares of the company. The buys took place at prices ranging from $3.40 to $3.52 per share, on dates ranging from June 13 to June 14, 2019. Miller now owns 1,156,007 shares of the company. Miller operates out of Burlingame, CA. Some additional info was provided as follows:
A portion of these shares is subject to a right of repurchase held by the Issuer.
These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.
The price re ported in Column 4 is a weighted price. These Shares were purchased in multiple transactions at prices ranging from $3.34 to $3.48 inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the Shares purchased at each separate price within the range set forth in this footnote.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Corvus Pharmaceuticals, Inc. makes a similar move, sign up!
Other recent filings from the company include the following:
On September - Sept. 17, 2020
Corvus Pharmaceuticals, Inc. director was just granted 30,000 options - Sept. 15, 2020
Corvus Pharmaceuticals, Inc. director just declared 0 ownership of the company. - Sept. 15, 2020
Departure of Directors or Certain - Sept. 11, 2020
On September - Sept. 10, 2020